Commodore Capital LP Merus N.V. Transaction History

Commodore Capital LP

$1.07 Billion
Q2 2025

A detailed history of Commodore Capital LP transactions in Merus N.V. stock. As of the latest transaction made, Commodore Capital LP holds 3,525,000 shares of MRUS stock, worth $225 Million. This represents 17.29% of its overall portfolio holdings.

Number of Shares

3,525,000

Previous 4,472,840 21.19%

Holding current value

$225 Million

Previous $188 Million 1.51%

% of portfolio

17.29%

Previous 18.43%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$34.89 - $62.42 $33.1 Million - $59.2 Million	-947,840 Reduced 21.19%	3,525,000 $185 Million
Q1 2025 May 15, 2025	BUY	$39.01 - $49.16 $23.4 Million - $29.4 Million	598,658 Added 15.45%	4,472,840 $188 Million
Q4 2024 Feb 14, 2025	BUY	$41.45 - $54.5 $21.7 Million - $28.6 Million	524,182 Added 15.65%	3,874,182 $163 Million
Q3 2024 Nov 14, 2024	BUY	$47.19 - $58.84 $7.08 Million - $8.83 Million	150,000 Added 4.69%	3,350,000 $167 Million
Q2 2024 Aug 14, 2024	SELL	$39.81 - $60.2 $46.2 Million - $69.8 Million	-1,160,000 Reduced 26.61%	3,200,000 $189 Million
Q1 2024 May 15, 2024	SELL	$28.03 - $51.82 $10.9 Million - $20.1 Million	-387,373 Reduced 8.16%	4,360,000 $196 Million
Q4 2023 Feb 14, 2024	BUY	$20.06 - $28.66 $6.41 Million - $9.15 Million	319,301 Added 7.21%	4,747,373 $131 Million
Q3 2023 Nov 14, 2023	BUY	$20.13 - $27.29 $8.62 Million - $11.7 Million	428,072 Added 10.7%	4,428,072 $104 Million
Q2 2023 Aug 14, 2023	BUY	$18.33 - $27.18 $19.2 Million - $28.5 Million	1,050,000 Added 35.59%	4,000,000 $105 Million
Q1 2023 May 15, 2023	BUY	$14.25 - $20.5 $3.1 Million - $4.46 Million	217,433 Added 7.96%	2,950,000 $54.3 Million
Q4 2022 Feb 14, 2023	BUY	$12.8 - $23.66 $1.5 Million - $2.76 Million	116,805 Added 4.47%	2,732,567 $42.3 Million
Q2 2022 Aug 15, 2022	BUY	$13.98 - $29.25 $11.2 Million - $23.4 Million	799,341 Added 44.01%	2,615,762 $59.2 Million
Q1 2022 May 16, 2022	BUY	$23.58 - $30.91 $7.49 Million - $9.81 Million	317,531 Added 21.18%	1,816,421 $48 Million
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $15.6 Million - $25.2 Million	780,754 Added 108.72%	1,498,890 $47.7 Million
Q3 2021 Nov 15, 2021	BUY	$16.48 - $27.23 $11.8 Million - $19.6 Million	718,136 New	718,136 $15.8 Million

Others Institutions Holding MRUS

# of Institutions

217

Shares Held

65.3M

Call Options Held

311K

Put Options Held

556K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.93B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.

Account

Commodore Capital LP Merus N.V. Transaction History